Gilead Sciences (MEX:GILD) E10: MXN89.95 (As of Mar. 2026)


MEX:GILD Gilead Sciences Inc MEX:GILD
76 GF Score
Price MXN2,217.67
GF Value MXN1,711.88
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Gilead Sciences E10?

Gilead Sciences MEX:GILD 76 E10 is MXN89.95 as of Mar. 2026. GuruFocus rates MEX:GILD with a GF Score™ of 76/100 and a GF Value™ of MXN1,711.88 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gilead Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN29.033. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN89.95 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Gilead Sciences's average E10 Growth Rate was -12.40% per year. During the past 3 years, the average E10 Growth Rate was -6.50% per year. During the past 5 years, the average E10 Growth Rate was 0.50% per year. During the past 10 years, the average E10 Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Gilead Sciences was 85.40% per year. The lowest was -6.50% per year. And the median was 17.80% per year.

As of today (2026-07-08), Gilead Sciences's current stock price is MXN2217.67. Gilead Sciences's E10 for the quarter that ended in Mar. 2026 was MXN89.95. Gilead Sciences's Shiller PE Ratio of today is 24.65.

During the past 13 years, the highest Shiller PE Ratio of Gilead Sciences was 30.63. The lowest was 9.93. And the median was 13.75.


Gilead Sciences  (MEX:GILD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Gilead Sciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2217.67/89.95
=24.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Gilead Sciences was 30.63. The lowest was 9.93. And the median was 13.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Gilead Sciences E10 Related Terms


Gilead Sciences E10 Historical Data

* Premium members only.

The historical data trend for Gilead Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gilead Sciences E10 Chart

Gilead Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.03 117.74 111.62 118.43 91.62

Gilead Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.08 103.61 99.96 91.62 89.95

MEX:GILD vs PFE, AMGN, BMY: E10 Comparison

For the Drug Manufacturers - General subindustry, Gilead Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gilead Sciences Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's Shiller PE Ratio falls into.


MEX:GILD
76GF Score
Gilead Sciences Inc MEX:GILD
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gilead Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gilead Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=29.033/330.2130*330.2130
=29.033

Current CPI (Mar. 2026) = 330.2130.

Gilead Sciences Quarterly Data

per share eps CPI Adj_EPS
201606 47.713 241.018 65.370
201609 48.145 241.428 65.850
201612 48.244 241.432 65.985
201703 38.599 243.801 52.280
201706 42.117 244.955 56.776
201709 37.385 246.819 50.016
201712 -58.133 246.524 -77.868
201803 21.256 249.554 28.126
201806 27.313 251.989 35.792
201809 29.928 252.439 39.149
201812 0.045 251.233 0.059
201903 29.873 254.202 38.806
201906 28.237 256.143 36.402
201909 -18.163 256.759 -23.359
201912 39.983 256.974 51.378
202003 28.607 258.115 36.598
202006 -61.398 257.797 -78.645
202009 6.406 260.280 8.127
202012 24.467 260.474 31.018
202103 28.004 264.877 34.912
202106 24.086 271.696 29.274
202109 42.152 274.310 50.742
202112 6.154 278.802 7.289
202203 0.398 287.504 0.457
202206 18.307 296.311 20.402
202209 28.563 296.808 31.778
202212 25.345 296.797 28.199
202303 14.420 301.836 15.776
202306 14.229 305.109 15.400
202309 30.135 307.789 32.330
202312 19.351 306.746 20.831
202403 -55.431 312.332 -58.604
202406 23.633 314.175 24.839
202409 19.690 315.301 20.621
202412 29.615 315.605 30.986
202503 21.277 319.799 21.970
202506 29.374 322.561 30.071
202509 44.576 324.800 45.319
202512 31.330 324.054 31.925
202603 29.033 330.213 29.033

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN89.95 mean?
Gilead Sciences (MEX:GILD) has a E10 of MXN89.95 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gilead Sciences and its competitors.
Is Gilead Sciences' E10 too high?
Gilead Sciences' current E10 is MXN89.95. Overall, Gilead Sciences has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gilead Sciences' E10 compare to PFE and AMGN?
Gilead Sciences' E10 of MXN89.95 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gilead Sciences and its competitors. Gilead Sciences's current E10 is MXN89.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gilead Sciences stock overvalued right now?
Based on GuruFocus' analysis, Gilead Sciences (MEX:GILD) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN1,711.88, compared to a current price of MXN2,217.67 — trading 29.5% above its estimated fair value. The current E10 is MXN89.95. Gilead Sciences' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Gilead Sciences (MEX:GILD), the current E10 is MXN89.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gilead Sciences (MEX:GILD) Overvalued in 2026?

Based on GuruFocus' analysis, Gilead Sciences stock appears to be overvalued. The current stock price of MXN2,217.67 is trading 29.5% above its estimated GF Value™ of MXN1,711.88. GuruFocus considers Gilead Sciences to be Modestly Overvalued.

Key valuation signals for MEX:GILD:

  • E10: MXN89.95
  • GF Value™: MXN1,711.88 vs. price of MXN2,217.67 (29.5% above fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the MEX:GILD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gilead Sciences Business Description

Address 333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
76GF Score

Get the complete analysis for MEX:GILD

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,217.67
Price
MXN1,711.88
GF Value